Gatekeeping and trailblazing: The role of biomarkers in novel guidelines for diagnosing Alzheimer’s disease
Crossref DOI link: https://doi.org/10.1057/s41292-017-0065-0
Published Online: 2017-07-31
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boenink, Marianne http://orcid.org/0000-0002-7017-0043
Funding for this research was provided by:
NWO Responsible Innovation (313-99-170)
License valid from 2017-07-31